Ibu-Lysin Dexcel

Ibuprofen lysinate, the active ingredient in Ibu-Lysin Dexcel, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats mild to moderate pain, fever and inflammatory conditions in adults and children as directed by a healthcare professional.

GNH USA supplies Ibu-Lysin Dexcel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibu-Lysin Dexcel, an NSAID, acts on inflammatory pathways to relieve several common conditions. - Mild to moderate pain: reduces pain intensity and improves functional ability. - Fever: lowers elevated body temperature associated with infection or inflammation. - Inflammatory conditions: diminishes swelling and discomfort in disorders such as arthritis or musculoskeletal injuries.

Adverse reactions may occur with any NSAID therapy.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe allergic reactions such as anaphylaxis. - Renal impairment or reduced kidney function. - Hepatic dysfunction, including elevated liver enzymes. - Cardiovascular events like myocardial infarction or stroke. - Severe cutaneous reactions (e.g., Stevens‑Johnson syndrome).

Before initiating therapy, consider the following safety measures. - Assess renal function: avoid use in patients with severe renal impairment. - Evaluate gastrointestinal risk: use gastro‑protective agents if history of ulcer disease. - Use the lowest effective dose for the shortest duration needed. - Avoid in individuals with known hypersensitivity to ibuprofen or other NSAIDs. - Monitor cardiovascular status in patients with existing heart disease. - Store at room temperature: keep in the original pack, protect from moisture.

Ibuprofen lysinate can affect the activity of several other medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Lithium: elevated lithium levels leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: enhanced risk of renal impairment. - Corticosteroids: increased gastrointestinal ulcer risk. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency. - Methotrexate: reduced clearance and potential toxicity.